Biological Company Startup Plan
As the society continues to progress, the startup plan is becoming more and more important to people, and the startup plan plays an important role in attracting the human resources needed by the entrepreneurs and gathering people's hearts and minds. Do you know the format of the business plan? Here is my help to organize the biological company business plan, welcome to read and collect.
Biological company business plan 1
I. Project Introduction:
1. Definition: biopharmaceutical refers to the use of microbiology, biology, medicine, biochemistry and other research results from organisms, biological tissues, cells, body fluids, etc., the comprehensive use of microbiology, chemistry, biochemistry and biotechnology, Pharmacy and other scientific principles and methods of manufacturing a class of products for prevention, treatment and diagnosis.
2. Raw materials: raw materials for biopharmaceuticals are mainly natural biological materials, including microorganisms, the human body, animals, plants, marine organisms and so on. With the development of biotechnology, purposeful artificial production of biological raw materials has become the main source of raw materials for biopharmaceuticals.
3. Product composition: vitamins, erythromycin, Zeomicin, etc., injectable penicillin, streptomycin, gentamicin, etc. is produced by fermentation with different microorganisms. The vast majority of antibiotics that have been used in medicine come from microorganisms, and each product has strict production standards. Predicting the progress of biopharmaceutical research, it will be widely used in the treatment of cancer, AIDS, coronary heart disease, anemia, dysplasia, diabetes and many other diseases.
Second, the service profile:
1. Service object: hospitals and other medical institutions and the demand for biopharmaceutical products and direct users.
2. Service institutions: Specialized service institutions should be set up, such as specialized consulting and after-sales service institutions in hospitals and residential areas.
3. Service personnel: to train a specialized team, mainly including sales staff, drug experts, lawyers, managers, information collectors, etc., focusing on the division of labor, cooperation and coordination.
4. Spirit of service: form a unique service culture, establish a first-class service image, and adhere to the principle of service first.
5. Service content: the R & D department should focus on research and development of new technologies to produce new products to satisfy consumers, to meet their new needs; consulting organizations are mainly responsible for answering the hospital doctors and patients and residents of the residential area of the drug-related information, and at the same time to play a role in the promotion of new products and the collection of their higher demand for information, so as to facilitate the company to develop new medicines, the promotion of new medicines and to further expand the product market; after-sales service organizations; and to promote new medicines. Product market; after-sales service organizations are mainly responsible for collecting the effect of the use of drugs, feedback to the headquarters and R & D departments, while dealing with some of the after-sales problem analysis and investigation and try to reduce the adverse effects.
6. Service model: the establishment of two-way contact between service personnel and consumers to strengthen communication and mutual supervision of the harmonious atmosphere.
Third, market analysis and forecast:
1. Market environment analysis: the camp of biological drugs is very large, and the development is also very fast. At present, half of the world's pharmaceutical products have been biosynthesized . The synthesis of biological drugs, especially the synthesis of complex molecular structure of the drug, it is not only easier than the chemical synthesis method, but also has a higher economic efficiency. In the past half century, microbial transformation in drug development in a series of breakthrough applications to the pharmaceutical industry to create a huge medical value and economic benefits.
(1) political and legal environment: biopharmaceutical technology content is high, so the technology is highly patented, so biopharmaceuticals in the legal barriers are very high, it is more difficult to enter.
(2) economic environment: with the rapid development of human society, the economic development is unprecedented, people can have more financial ability to invest in medical and health care, while science and technology is changing rapidly, the technology of biopharmaceuticals will be gradually mature and updated, so from the general trend, biopharmaceuticals will have a broad market demand.
(3) Social culture: with the improvement of people's living standards, people pay more attention to their own health problems, so biopharmaceuticals can be very good to meet this demand, and there is no substitute.
(4) Technical analysis: the technical requirements of biopharmaceuticals are very high, not only to prevent new competitors from joining, but also in the leading technology can be in the existing competitive conditions of the industry pre-emptive.
2. Market Demand Analysis: As there are many product categories of biopharmaceuticals, the market demand for biopharmaceuticals is broad and diversified, such as therapeutic drugs to meet the needs of patients' treatment, and health care drugs for the vast majority of the population with a sense of health care to promote the use of the majority of the population. From the current point of view, many people are more or less accustomed to using medicines, and many medicines are commonly kept at home. In terms of people's general health condition, many people are in the sub-health stage, coupled with the decline in people's overall physical quality, people have become somewhat dependent on drugs. Whether for the treatment of disease, or for the prevention of disease or other unhealthy conditions, people will choose to use drugs or other health care products, so the products of biopharmaceuticals will also appear in some of the gifts and exchanges. In the long run, with the progress of human society and the rapid development of economy, people will pay more and more attention to their own health, and with the improvement of people's life expectancy, the aging of the population is becoming more and more prominent, and the demand for biopharmaceutical products for the elderly will be a major demand. In addition, with the development of science and technology, people's demand for biopharmaceutical products will be continuously satisfied. Comprehensive analysis of the above, we can draw a conclusion: the biopharmaceutical market is vast potential, and has the possibility of expansion.
3. Market competition analysis: from the characteristics of the biopharmaceutical industry can be seen that this industry is a technology-intensive industry, and both capital-intensive industry, so the market competitiveness of biopharmaceutical companies is mainly reflected in the enterprise's R & D and capital and scale. I will analyze these three aspects, first of all, technology is the fundamental survival of biopharmaceutical companies, no advanced and updated technology is difficult to get a foothold in this industry, even if the temporary survival can not get rid of the fate of the final elimination. Speaking of technology, we can not talk about innovation, biopharmaceutical companies need to have the ability to innovate and a group of innovative research and development personnel and teams. Then, the biopharmaceutical enterprise should have enough capital flow, and must ensure the operation of the R & D funds. If there is not enough capital, then there is a risk of being limited in competition. Finally, the size of the biopharmaceutical enterprise is a very important issue because it is both a result of the first two, but also can promote the better development and goal achievement of both from the side. The size of the enterprise should be appropriate to ensure normal operation and at the same time have the possibility of further development. Looking at the companies in the biopharmaceutical industry nowadays, they are very competitive in general, but all of them are able to have some benefits. These companies are trying to make themselves able to stand out, so they are all working on these three aspects, hoping for a breakthrough.
Four, marketing strategy.
1. Sales channels: the principle (according to different products to develop different sales strategies and programs. The structure of the marketing system is to establish a sales system by object and a marketing system by product to form a matrix-covered marketing network).
(1) For therapeutic and diagnostic drugs, the company should promote them to medical institutions such as major hospitals and major pharmacies, and at the same time provide appropriate feedback and improvement through the use of patients.
(2) for health care products, the company should face the health care products market to enter, take the distribution approach in major supermarkets and other retail parties to promote.
2. Sales plan:
(1) to build a strong marketing team we attach importance to cultivate a high-quality, team spirit of sales engineers and marketing managers team, attach importance to the discovery and cultivation of strategic marketing management talent and international marketing talent we want to build the marketing team with a long-term goal to *** the same cause, responsibility, honor to motivate and drive.
(2) General discussion to establish the marketing program.
(3) Implementation of the program.
(4) carry out market research, collect sales information, summarize the pros and cons of the marketing program, overall discussion for improvement.
3. Customer relations: both to ensure communication and contact with large customers, but also to develop relationships with small and medium-sized customers.
Biological company business plan 21 Company Profile
Green Friends Biotechnology Co., Ltd. is a research and development of new yogurt fermentation agent is the main company, it has a new yogurt fermentation agent production of patented technology, and advocate science and technology based on the new concept of green environmental protection, through the promotion and popularization of the yogurt fermentation agent, to provide mankind with the best natural products We have a patented technology for the production of new yogurt fermenter and advocate the new concept of technology-based green environmental protection.
2 Market Opportunities
2.1 Market Demand
Lactobacilli are commonly used in the manufacture of yogurt, cheese, sauerkraut, beer, wine, kimchi, pickles and other fermented foods. Adding lactobacilli to milk improves the health benefits of milk.
Lactobacillus is a probiotic beneficial to human health, mainly in the human intestinal tract, when it reaches a certain number, it can improve the regulation of the balance of intestinal microflora, lactobacilli metabolites can reduce the intestinal pH, inhibit the growth of intestinal putrefactive bacteria and attenuate the putrefactive bacterial toxicity in the intestinal tract, and can help to help digestion, to prevent constipation, to prevent aging of the cells, to enhance immunity, to reduce cholesterol levels, and to help digestion and constipation. It also helps digestion, prevents constipation, prevents cell aging, strengthens the body's immunity, lowers cholesterol levels, relieves lactose intolerance and inhibits the formation of tumor cells. Nowadays, lactic acid bacteria products are getting more and more attention in the development of natural and functional food, which puts forward new requirements on the quality and types of lactic acid bacteria fermentation agent. At present, the traditional lactic acid bacteria fermentation agent is gradually abandoned due to various disadvantages, and will be replaced by one-time direct-pitch powder fermentation agent. This kind of fermenter has the characteristics of high vitality, small volume, easy to carry and use, not only can be used directly for the production of fermented dairy products, but also can be used as food additives or directly eaten, eliminating the need to expand the culture of the complex process, thus simplifying the production process, helping to maintain product quality and stability, and to prevent the degradation of the bacterial strain and pollution.
2.2 Competitive analysis of the industry
Through the survey, the fermentation agent sales company is still mainly chemical fertilizer, but also a small number of biological fermentation agent. Chemical ferments can no longer meet the production needs of green agricultural products, and the existing biological ferments are not accepted by the majority of agricultural producers due to high prices and complex production processes. The fermentation agent market is lacking a good price, high efficiency of the biological fermentation agent, and my company's production of yogurt fermentation agent is in line with such requirements, has a strong market competitiveness.
2.3 Comparison of main rival products
2.4 Competitive advantage analysis
We have made a long-term investigation on all kinds of bio-fermenter products and Lactobacillus agent related products in the market, and have examined and compared their products, and y understood several bio-fermenter enterprises with a large market share, and we think that our company's scale of production, level of equipment, and technological ideas, We believe that our production scale, equipment level, technical idea and product quality are at the leading level. And based on the technological advantage, we have formed a price advantage.
The company researches and develops new products with the Food Science and Technology College of Hebei Agricultural University***, which has advanced technology, and the technical team composed of professors from Hebei Agricultural University does quality assurance, and the products will be continuously improved and updated, and the market competitiveness will be continuously improved.
Through the continuous updating of technology, while continuously improving the quality of products, we will launch diversified products to expand the market, and at the same time, through the progress of the company's management to **** with the maintenance of our competitive advantage.
3 Development Strategy
The company attaches importance to the combination of short-term goals and long-term strategy.
3.1 Initial stage (1-3 years)
The main product is Lactobacillus fermentation agent, the market strategy is to capture the market share of agricultural fermentation agent, to establish their own brand, the formation of intangible assets, to recover the initial investment, the research and development of derivative products.
In the first two years, the product is introduced into the market, improve product awareness, establish brand image, and gradually establish a sound sales network to open and initially occupy the agricultural fermentation market.
2-3 years, improve brand image, increase intangible assets, increase equipment, expand the production scale; enhance the annual output and market share; product maturity, focus on research and development of new products, development of derivative products, expand the market.
3.2 Medium-term (4-6 years)
Further improve and perfect the production and sales network; according to the initial production and sales situation, determine the key sales areas, and establish large-scale production and wholesale centers in the key areas. At the same time, we will develop new products and implement diversified business strategies, so that the market share will gradually become dominant. Consolidate and expand the market of bio-fermentation agent, and maintain the continuous development of technology.
3.3 Long-term (5-10 years)
Utilizing the company's technological advantage of Lactobacillus biofermentation agent, developing and researching AM bio-agent related products, realizing product diversification, expanding the market space, expanding the market share, and becoming the leader in the field of agricultural bio-agent processing, and becoming the R&D center of biotechnology bio-fermentation agents, and the center of production and sales.
Green Friends Biotechnology LLC business plan (business plan outline), the company's registered capital of 2.5 million yuan share capital structure scale is as follows:, according to the forecast of the future state of the company's operations, the company is able to maintain high profit growth, the company's first year does not share the dividend, the manager of the Department of Technology, the company's management team for the general manager of a general manager, entrepreneurial passion to assist in the management of the company to make the company stable and rapid forward development. Initially, the company was able to stabilize the rapid forward development.
4 investment and income
4.1 Share capital structure and size
The company's registered capital of 2.5 million yuan, the size of the share capital structure is as follows:
Through the net cash flow, the discount rate, the amount of investment and other data using the difference method of calculating the payback period of two years and one month, the investment program is feasible.
Payback period=Number of years with positive cumulative NPV-1+(unrecovered cash/present value of the year)
4.3 Embedded rate of return (IRR)
According to the calculation of cash flow, the embedded rate of return is as follows:
n
NPV(IRR)= ∑(CI-CO)t(1+IRR)-t(1+IRR)t(1+IRR)-(1+IRR) t(1+IRR)-t=0
t =1
IRR=34.69%
IRR reaches 34.69%, which is much larger than the cost of capital rate of 7%, mainly because of the high quality and low price of this product, which makes the sales profit margins high, and also, the market growth in the first 5 years is very good.
4.4 Return on Investment
According to the prediction of the company's future operating conditions, the company is able to maintain high profit growth, and intends to withdraw a reasonable proportion of net profit as a return to shareholders. For this reason, the company will not pay dividends in the first year, and will pay dividends as a percentage of net profit every year after the second year.
5 Management Team
General Manager of the Board of Directors Manager of the Quality Inspection Department
Manager of the Technical Department
Manager of the Sales Department
Manager of the Public Relations Department
Manager of the Production Department
Manager of the Sales Department
Manager of the Financial Department
The Company's management team consists of a general manager, under which there are seven managers. The team consists of a general manager and seven department managers. We are a team of university students, full of passion for entrepreneurship, innovative and complementary strengths, **** with the formation of an excellent team. Although we lack practical experience, we have a serious and responsible attitude and the spirit of continuous improvement. For the lack of knowledge, we will continue to learn, for the lack of experience, we will continue to accumulate, so that we gradually evolve into an outstanding management team.
At the same time, we will also hire some excellent management personnel to help manage the company, so that the company can be stable and rapid development of the initial period.
;